person · Reporting owner
Schikan Johannes Gerardus Christiaan Petrus
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Pharvaris N.V.PHVS · Entity 4374 | Director | September 22, 2026 | September 24, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Pharvaris N.V.
Report date September 22, 2026 · Filed September 24, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 115,167 |
Ending reported balance
After 2026-09-22 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-09-22 · Exercise / conversion · Acquired 800 · Balance 115,967 Row 2 · 2026-09-22 · Sale · Disposed 800 · Balance 115,167 F1: The reported price represents a weighted average sale price for shares sold in multiple transactions on the reported date. The shares were sold in connection with the exercise of stock options in a cashless exercise transaction. The sales prices for the transactions ranged from $36.15 to $36.23. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $20.00 · Expires 2031-02-05 | Direct | 34,200 |
Reported balance
After 2026-09-22 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-09-22 · Exercise / conversion · Disposed 800 · Balance 34,200 F2: 25% of the option vested on February 5, 2022 with the remaining shares vesting in 1/48 monthly installments thereafter. |
Filing footnotes · ownership attribution and instrument terms
F1: The reported price represents a weighted average sale price for shares sold in multiple transactions on the reported date. The shares were sold in connection with the exercise of stock options in a cashless exercise transaction. The sales prices for the transactions ranged from $36.15 to $36.23. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
F2: 25% of the option vested on February 5, 2022 with the remaining shares vesting in 1/48 monthly installments thereafter.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 22, 2026 Filed Sep 24, 2026 14:43 UTC | Pharvaris N.V. PHVS · Entity 4374 | Exercise / conversionStock Option (Right to Buy) · Derivative | 800 | $0.00 Strike: $20.00 | $0.00 |
DisclosureSEC source: 0001193125-26-400435 · ownership.xml · derivative · entry 3 Schikan Johannes Gerardus Christiaan Petrus · CIK 0002014983 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,200 Underlying: Common Stock · 800 shares Expires 2031-02-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 25% of the option vested on February 5, 2022 with the remaining shares vesting in 1/48 monthly installments thereafter. Read SEC document |
| September 22, 2026 Filed Sep 24, 2026 14:43 UTC | Pharvaris N.V. PHVS · Entity 4374 | SaleCommon Stock | 800 | $36.19 | $28,952.00 |
DisclosureSEC source: 0001193125-26-400435 · ownership.xml · nonDerivative · entry 2 Schikan Johannes Gerardus Christiaan Petrus · CIK 0002014983 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 115,167 F1 · price: The reported price represents a weighted average sale price for shares sold in multiple transactions on the reported date. The shares were sold in connection with the exercise of stock options in a cashless exercise transaction. The sales prices for the transactions ranged from $36.15 to $36.23. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| September 22, 2026 Filed Sep 24, 2026 14:43 UTC | Pharvaris N.V. PHVS · Entity 4374 | Exercise / conversionCommon Stock | 800 | $20.00 | $16,000.00 |
DisclosureSEC source: 0001193125-26-400435 · ownership.xml · nonDerivative · entry 1 Schikan Johannes Gerardus Christiaan Petrus · CIK 0002014983 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 115,967 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 17, 2026 Filed Sep 21, 2026 20:18 UTC | Pharvaris N.V. PHVS · Entity 4374 | SaleCommon Stock | 200,000 | $35.00 | $7,000,000.00 |
DisclosureSEC source: 0001193125-26-396689 · ownership.xml · nonDerivative · entry 1 Schikan Johannes Gerardus Christiaan Petrus · CIK 0002014983 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 115,167 Read SEC document |
| June 30, 2026 Filed Jul 1, 2026 23:06 UTC | Pharvaris N.V. PHVS · Entity 4374 | SaleCommon Stock | 30,712 | $35.49 | $1,090,048.73 |
DisclosureSEC source: 0001193125-26-292962 · ownership.xml · nonDerivative · entry 2 Schikan Johannes Gerardus Christiaan Petrus · CIK 0002014983 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 315,167 F1 · kind: This is a scheduled sale from 10b5-1 trading plan. F3 · price: The reported price represents a weighted average sale price for shares sold in multiple transactions on the reported date pursuant to a Rule 10b5-1 trading plan. The sales prices for the transactions ranged from $35.00 to $35.90. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 29, 2026 Filed Jun 29, 2026 22:18 UTC | Pharvaris N.V. PHVS · Entity 4374 | SaleCommon Stock | 2,400 | $35.10 | $84,249.84 |
DisclosureSEC source: 0001193125-26-288840 · ownership.xml · nonDerivative · entry 1 Schikan Johannes Gerardus Christiaan Petrus · CIK 0002014983 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 352,767 F1 · kind: This is a scheduled sale from 10b5-1 trading plan. F2 · price: The reported price represents a weighted average sale price for shares sold in multiple transactions on the reported date pursuant to a Rule 10b5-1 trading plan. The shares reported herein include shares of common stock acquired upon vesting of restricted stock units on various dates. The sales prices for the transactions ranged from $35.00 to $35.30. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 29, 2026 Filed Jul 1, 2026 23:06 UTC | Pharvaris N.V. PHVS · Entity 4374 | SaleCommon Stock | 6,888 | $35.05 | $241,447.13 |
DisclosureSEC source: 0001193125-26-292962 · ownership.xml · nonDerivative · entry 1 Schikan Johannes Gerardus Christiaan Petrus · CIK 0002014983 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 345,879 F1 · kind: This is a scheduled sale from 10b5-1 trading plan. F2 · price: The reported price represents a weighted average sale price for shares sold in multiple transactions on the reported date pursuant to a Rule 10b5-1 trading plan. The sales prices for the transactions ranged from $35.00 to $35.10 The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| April 30, 2026 Filed May 1, 2026 23:32 UTC | Pharvaris N.V. PHVS · Entity 4374 | SaleCommon Stock | 670 | $31.03 | $20,791.51 |
DisclosureSEC source: 0001193125-26-201931 · ownership.xml · nonDerivative · entry 3 Schikan Johannes Gerardus Christiaan Petrus · CIK 0002014983 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 355,167 F1 · kind: This is a scheduled sale from 10b5-1 trading plan. F4 · price: The reported price represents a weighted average sale price for shares sold in multiple transactions on the reported date pursuant to a Rule 10b5-1 trading plan. The shares reported herein include shares of common stock acquired upon vesting of restricted stock units on various dates. The sales prices for the transactions ranged from $31.03 to $31.05. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| April 30, 2026 Filed May 1, 2026 23:32 UTC | Pharvaris N.V. PHVS · Entity 4374 | SaleCommon Stock | 28,400 | $30.30 | $860,588.16 |
DisclosureSEC source: 0001193125-26-201931 · ownership.xml · nonDerivative · entry 2 Schikan Johannes Gerardus Christiaan Petrus · CIK 0002014983 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 355,837 F1 · kind: This is a scheduled sale from 10b5-1 trading plan. F3 · price: The reported price represents a weighted average sale price for shares sold in multiple transactions on the reported date pursuant to a Rule 10b5-1 trading plan. The shares reported herein include shares of common stock acquired upon vesting of restricted stock units on various dates. The sales prices for the transactions ranged from $30.00 to $30.99. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| April 29, 2026 Filed May 1, 2026 23:32 UTC | Pharvaris N.V. PHVS · Entity 4374 | SaleCommon Stock | 3,830 | $30.07 | $115,165.04 |
DisclosureSEC source: 0001193125-26-201931 · ownership.xml · nonDerivative · entry 1 Schikan Johannes Gerardus Christiaan Petrus · CIK 0002014983 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 384,237 F1 · kind: This is a scheduled sale from 10b5-1 trading plan. F2 · price: The reported price represents a weighted average sale price for shares sold in multiple transactions on the reported date pursuant to a Rule 10b5-1 trading plan. The shares reported herein include shares of common stock acquired upon vesting of restricted stock units on various dates. The sales prices for the transactions ranged from $30.00 to $30.18. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| April 23, 2026 Filed Apr 24, 2026 18:09 UTC | Pharvaris N.V. PHVS · Entity 4374 | SaleCommon Stock | 100 | $30.03 | $3,003.00 |
DisclosureSEC source: 0001193125-26-176673 · ownership.xml · nonDerivative · entry 2 Schikan Johannes Gerardus Christiaan Petrus · CIK 0002014983 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 388,067 F1 · kind: This is a scheduled exercise and sale from 10b5-1 trading plan. Read SEC document |
| April 22, 2026 Filed Apr 24, 2026 18:09 UTC | Pharvaris N.V. PHVS · Entity 4374 | SaleCommon Stock | 7,000 | $30.05 | $210,378.70 |
DisclosureSEC source: 0001193125-26-176673 · ownership.xml · nonDerivative · entry 1 Schikan Johannes Gerardus Christiaan Petrus · CIK 0002014983 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 388,167 F1 · kind: This is a scheduled exercise and sale from 10b5-1 trading plan. F2 · price: These shares were sold in multiple transactions at prices ranging from $30 - $30.13. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.